Bristol-Myers Partners Array to Investigate Cancer Candidate
Bristol-Myers Squibb Company BMY and Array BioPharma ARRY entered into a clinical research collaboration to investigate the safety, tolerability and efficacy of Array's binimetinib in combination with Bristol-Myers Squibb's Opdivo (nivolumab) and Opdivo + Yervoy (ipilimumab) regimen. The combination will be assessed to treat metastatic colorectal cancer in patients with microsatellite stable tumors. Bristol-Myers’ shares have lost 7.7% year to date against the Zacks classified Large Cap Pharmaceuticals industry’s gain of 9.1% […]